# K091898: Blood Glucose Monitoring System, Model Fora G90/TD-4234

- Pathway: 510(k) (Special)
- Applicant: Taidoc Technology Corporation
- Decided: Sep 18, 2009 after 86 days
- Product code: NBW (System, Test, Blood Glucose, Over The Counter)
- Device class: 2
- Regulation: 21 CFR 862.1345
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
1 later device descends from it; 1 cites it directly.
0 of 2 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Most influential descendants
- K100405: Fora G90 Perform Blood Glucose Monitoring System (2010), 0 descendants of its own

## Indications for use
The FORA G90 / U-Right TD-4234 Blood Glucose Monitoring System is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and the following alternative sites: the palm, the forearm, the upper-arm, the calf and the thigh. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, nor is it intended for use on newborns. The alternative site testing in this system can be used only during steady-state blood glucose conditions.

Source page: https://510kreport.com/device/K091898
Methodology: https://510kreport.com/methodology